LAGUNA HILLS, Calif., Aug. 19, 2019 /PRNewswire/ — Adagio Medical, Inc. (Adagio), the developer of iCLAS™, the company’s ultra-low temperature intelligent continuous lesion ablation system, announced that it has received an Investigational Device Exemption approval with conditions from the US Food and Drug Administration (FDA) to conduct a non-randomized, single-arm clinical study for persistent atrial […]
Tag: Adagio Medical
Audio: Hakon Bergheim, COO of Adagio Medical speaks with CardiacVascularNews
Audio recording: Hakon Bergheim, COO of Adagio Medical speaks with CardiacVascularNews
Recent
Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications
ACHIEVE-4, the longest Phase 3 study of Lilly’s Foundayo (orforglipron) to date, reaffirmed its cardiovascular and overall safety profile as well as consistent improvements across key measures of cardiometabolic health
Nicklaus Children’s Hospital’s Heart Institute Performs Florida’s First Partial Heart Transplant
Popular
- No commented posts yet